Gene · 3713
Papers3,772
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 3,772
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Desmosomes as Signaling Hubs in the Regulation of Cell Behavior. | Front Cell Dev Biol | 2021 | 34631720 | PubTator, text mining | PubMed |
| RN7SK small nuclear RNA controls bidirectional transcription of highly expressed gene pairs in skin. | Nat Commun | 2021 | 34620876 | PubTator, text mining | PubMed |
| Low expression of endoplasmic reticulum stress-related gene SERP1 is associated with poor prognosis and immune infiltration in skin cutaneous melanoma. | Aging (Albany NY) | 2021 | 34613934 | PubTator, text mining | PubMed |
| The eIF2 kinase GCN2 directs keratinocyte collective cell migration during wound healing via coordination of reactive oxygen species and amino acids. | J Biol Chem | 2021 | 34597669 | PubTator, text mining | PubMed |
| Urea in Dermatology: A Review of its Emollient, Moisturizing, Keratolytic, Skin Barrier Enhancing and Antimicrobial Properties. | Dermatol Ther (Heidelb) | 2021 | 34596890 | PubTator, text mining | PubMed |
| Construction of a high fidelity epidermis-on-a-chip for scalable in vitro irritation evaluation. | Lab Chip | 2021 | 34581381 | PubTator, text mining | PubMed |
| Partially Hydrolysed Whey-Based Infant Formula Improves Skin Barrier Function. | Nutrients | 2021 | 34578990 | PubTator, text mining | PubMed |
| FAK Shutdown: Consequences on Epithelial Morphogenesis and Biomarker Expression Involving an Innovative Biomaterial for Tissue Regeneration. | Int J Mol Sci | 2021 | 34575938 | PubTator, text mining | PubMed |
| Comparative In Vitro Evaluation of Commercial Periodontal Gels on Antibacterial, Biocompatibility and Wound Healing Ability. | Pharmaceutics | 2021 | 34575578 | PubTator, text mining | PubMed |
| The Genetic Variants of NOTCH3 (6746T>C) and PSMA6 (-8C>G) as Possible Risk Factors of Psoriasis Development. | Life (Basel) | 2021 | 34575036 | PubTator, text mining | PubMed |
| The Pathogenic and Therapeutic Implications of Ceramide Abnormalities in Atopic Dermatitis. | Cells | 2021 | 34572035 | PubTator, text mining | PubMed |
| Accelerated Barrier Repair in Human Skin Explants Induced with a Plant-Derived PPAR-α Activating Complex via Cooperative Interactions. | Clin Cosmet Investig Dermatol | 2021 | 34566418 | PubTator, text mining | PubMed |
| CXCL10 and its related key genes as potential biomarkers for psoriasis: Evidence from bioinformatics and real-time quantitative polymerase chain reaction. | Medicine (Baltimore) | 2021 | 34559160 | PubTator, text mining | PubMed |
| EGFR-mediated epidermal stem cell motility drives skin regeneration through COL17A1 proteolysis. | J Cell Biol | 2021 | 34550317 | PubTator, text mining | PubMed |
| Development of a 3D psoriatic skin model optimized for infiltration of IL-17A producing T cells: Focus on the crosstalk between T cells and psoriatic keratinocytes. | Acta Biomater | 2021 | 34547515 | PubTator, text mining | PubMed |
| Regulation of integrin and extracellular matrix genes by HNRNPL is necessary for epidermal renewal. | PLoS Biol | 2021 | 34543262 | PubTator, text mining | PubMed |
| Systematic Review on the Efficacy and Safety of Oral Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis. | Front Med (Lausanne) | 2021 | 34540860 | PubTator, text mining | PubMed |
| Overexpression of Lin28a Aggravates Psoriasis-Like Phenotype by Regulating the Proliferation and Differentiation of Keratinocytes. | J Inflamm Res | 2021 | 34511969 | PubTator, text mining | PubMed |
| Cystatin-B Negatively Regulates the Malignant Characteristics of Oral Squamous Cell Carcinoma Possibly Via the Epithelium Proliferation/Differentiation Program. | Front Oncol | 2021 | 34504787 | PubTator, text mining | PubMed |
| Alterations of Ultra Long-Chain Fatty Acids in Hereditary Skin Diseases-Review Article. | Front Med (Lausanne) | 2021 | 34497816 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3713/papers?page=41